Washington University’s Center for Vaccines and Immunity to Microbial Pathogens (CVIMP) goal is to facilitate seamless interactions between the tremendous clinical expertise at Washington University School of Medicine (WUSM) and its world-renowned basic science departments.
Known pathogens, such as influenza viruses, HIV, TB, and malaria, and the emergence of new pathogens, such as the Zika virus and SARS-CoV-2, continue to represent frequent and significant threats to human health. Novel or improved vaccines and therapeutics are desperately needed across various infectious disease disciplines.
CVIMP targets all different stages of vaccine development that range from basic vaccine platform development, pivotal animal studies, detailed laboratory-based analysis of immune responses and correlates of protection, GMP production facilities, administrative infrastructure for IND filing, and a clinical trials group that can design and run phase I and II studies.
Latest Events
2025 Rising Stars Seminar Series
Times: 3-4 PM CST
January 7th – Brett Case, Washington University School of Medicine
February 11 – Seth Zost, Vanderbilt University
March 4 – Hanover Matz, Washington University School of Medicine
April 1 – Alexander Cohen, California Institute of Technology
May 13 – Alba Grifoni, La Jolla Institute of Immunology
June 3 – Cassie Simonich, Fred Hutchinson Cancer Research Center
July 1 – Daniel Wrapp, Duke University
August 5 – Paeton Wantuch, Washington University School of Medicine
September 2 – Anass Abbad, Icahn School of Medicine Mount Sinai
October 7 – Emanuele Andreano, Fondazione Toscana Life Sciences
November 4 – John Gridley, Emory University
December 2 – Doan Nguyen and Violeta Capric, Emory University
Latest News
Our vision is to amplify and accelerate the translational impact of the cutting-edge research performed at WUSM that dissects the interplay between our immune system and microbial pathogens.
$12 million grant aimed at probing how vaccines induce lasting immunity (Links to an external site)
WashU Medicine leads 2 major pandemic preparedness research projects (Links to an external site)
